These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats. Ucak A; Onan B; Güler A; Sahin MA; Kılıçkaya O; Oztaş E; Uysal B; Arslan S; Yılmaz AT Ann Vasc Surg; 2011 Jul; 25(5):686-95. PubMed ID: 21724106 [TBL] [Abstract][Full Text] [Related]
45. Influence of combined therapy with rosuvastatin and amitriptyline on the oxidation-reduction status in rats. Herbet M; Gawrońska-Grzywacz M; Graca A; Jagiełło-Wójtowicz E Acta Pol Pharm; 2013; 70(5):913-7. PubMed ID: 24147371 [TBL] [Abstract][Full Text] [Related]
47. Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation. Corna D; Sangalli F; Cattaneo D; Carrara F; Gaspari F; Remuzzi A; Zoja C; Benigni A; Perico N; Remuzzi G Am J Nephrol; 2007; 27(6):630-8. PubMed ID: 17851231 [TBL] [Abstract][Full Text] [Related]
48. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells. Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697 [TBL] [Abstract][Full Text] [Related]
49. Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes. Miersch S; Sliskovic I; Raturi A; Mutus B Free Radic Biol Med; 2007 Jan; 42(2):270-9. PubMed ID: 17189832 [TBL] [Abstract][Full Text] [Related]
50. Rosuvastatin ameliorates diabetes-induced reproductive damage via suppression of oxidative stress, inflammatory and apoptotic pathways in male rats. Heeba GH; Hamza AA Life Sci; 2015 Nov; 141():13-9. PubMed ID: 26407473 [TBL] [Abstract][Full Text] [Related]
51. Enhanced effect of losartan and rosuvastatin on neointima hyperplasia. Yi I; Lee JJ; Park JS; Zhang WY; Kim IS; Kim Y; Shin CY; Kim HS; Myung CS Arch Pharm Res; 2010 Apr; 33(4):593-600. PubMed ID: 20422369 [TBL] [Abstract][Full Text] [Related]
52. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Lu TM; Ding YA; Leu HB; Yin WH; Sheu WH; Chu KM Am J Cardiol; 2004 Jul; 94(2):157-61. PubMed ID: 15246890 [TBL] [Abstract][Full Text] [Related]
53. Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart. Ozturk N; Yaras N; Ozmen A; Ozdemir S J Bioenerg Biomembr; 2013 Aug; 45(4):343-52. PubMed ID: 23640692 [TBL] [Abstract][Full Text] [Related]
54. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice. Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361 [TBL] [Abstract][Full Text] [Related]
55. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells. Landsberger M; Jantzen F; Könemann S; Felix SB Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089 [TBL] [Abstract][Full Text] [Related]
56. Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects. Patterson KA; Zhang X; Wrobleski SK; Hawley AE; Lawrence DA; Wakefield TW; Myers DD; Diaz JA Thromb Res; 2013 Mar; 131(3):268-76. PubMed ID: 23276528 [TBL] [Abstract][Full Text] [Related]
57. Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice. Desjardins F; Sekkali B; Verreth W; Pelat M; De Keyzer D; Mertens A; Smith G; Herregods MC; Holvoet P; Balligand JL Eur Heart J; 2008 Jan; 29(1):128-37. PubMed ID: 18063594 [TBL] [Abstract][Full Text] [Related]
58. Possible effects of rosuvastatin on noise-induced oxidative stress in rat brain. Ersoy A; Koc ER; Sahin S; Duzgun U; Acar B; Ilhan A Noise Health; 2014; 16(68):18-25. PubMed ID: 24583676 [TBL] [Abstract][Full Text] [Related]
59. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders. Mahalwar R; Khanna D Eur J Pharmacol; 2013 Jul; 711(1-3):57-62. PubMed ID: 23648561 [TBL] [Abstract][Full Text] [Related]
60. Rosuvastatin in experimental brain trauma: improved capillary patency but no effect on edema or cerebral blood flow. Jungner M; Lundblad C; Bentzer P Microvasc Res; 2013 Jul; 88():48-55. PubMed ID: 23538316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]